Cargando…
COVID-19 and immunomodulator/immunosuppressant use in dermatology
Autores principales: | Price, Kyla N., Frew, John W., Hsiao, Jennifer L., Shi, Vivian Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156805/ https://www.ncbi.nlm.nih.gov/pubmed/32224277 http://dx.doi.org/10.1016/j.jaad.2020.03.046 |
Ejemplares similares
-
Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic
por: Price, Kyla N., et al.
Publicado: (2020) -
COVID-19 and its effect on medical student education in dermatology
por: Loh, Tiffany Y., et al.
Publicado: (2020) -
Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic
por: Trinidad, John, et al.
Publicado: (2020) -
Optimizing care for atopic dermatitis patients during the COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020) -
Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits
por: Kwatra, Shawn G., et al.
Publicado: (2020)